C20orf181
|
|
chromosome 20 open reading frame 181
|
|
246
|
0.479 |
0.885 |
|
0.070 |
None
|
1.000 |
7
|
0
|
2006 |
2019 |
Entrez Id: |
406991 |
Gene Symbol: |
MIR21 |
MIR21
|
|
microRNA 21
|
|
726
|
0.363 |
0.846 |
|
0.040 |
None
|
1.000 |
4
|
0
|
2010 |
2018 |
Entrez Id: |
100616444 |
Gene Symbol: |
ERVK-20 |
ERVK-20
|
|
endogenous retrovirus group K member 20
|
|
143
|
0.533 |
0.692 |
|
0.030 |
None
|
1.000 |
3
|
0
|
1995 |
2019 |
Entrez Id: |
406938 |
Gene Symbol: |
MIR146A |
MIR146A
|
|
microRNA 146a
|
|
505
|
0.398 |
0.885 |
|
0.030 |
None
|
1.000 |
3
|
0
|
2012 |
2020 |
Entrez Id: |
17 |
Gene Symbol: |
AAVS1 |
AAVS1
|
|
adeno-associated virus integration site 1
|
|
78
|
0.595 |
0.731 |
|
0.020 |
None
|
1.000 |
2
|
0
|
2013 |
2014 |
Entrez Id: |
2477 |
Gene Symbol: |
FRAXA |
FRAXA
|
|
fragile site, folic acid type, rare, fra(X)(q27.3) A (macroorchidism, mental retardation)
|
|
50
|
0.641 |
0.462 |
|
0.020 |
None
|
1.000 |
2
|
0
|
2003 |
2005 |
Entrez Id: |
406921 |
Gene Symbol: |
MIR132 |
MIR132
|
|
microRNA 132
|
|
222
|
0.485 |
0.846 |
|
0.020 |
None
|
1.000 |
2
|
0
|
2014 |
2015 |
Entrez Id: |
64006 |
Gene Symbol: |
ERVK-6 |
ERVK-6
|
|
endogenous retrovirus group K member 6, envelope
|
|
162
|
0.521 |
0.808 |
|
0.020 |
None
|
1.000 |
2
|
0
|
2014 |
2019 |
TRBV20OR9-2
|
|
T cell receptor beta variable 20/OR9-2 (non-functional)
|
|
456
|
0.403 |
0.923 |
|
0.020 |
None
|
1.000 |
2
|
0
|
2001 |
2008 |
CDKN2B-AS1
|
|
CDKN2B antisense RNA 1
|
|
213
|
0.491 |
0.769 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2015 |
2015 |
Entrez Id: |
100126311 |
Gene Symbol: |
MIR147B |
MIR147B
|
|
microRNA 147b
|
|
20
|
0.736 |
0.423 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2018 |
2018 |
Entrez Id: |
100775105 |
Gene Symbol: |
ERVK-18 |
ERVK-18
|
|
endogenous retrovirus group K member 18
|
|
106
|
0.560 |
0.654 |
|
0.010 |
None
|
1.000 |
1
|
0
|
1995 |
1995 |
Entrez Id: |
106478973 |
Gene Symbol: |
FMR1-IT1 |
FMR1-IT1
|
|
FMR1 intronic transcript 1
|
|
29
|
0.716 |
0.385 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2005 |
2005 |
Entrez Id: |
110006328 |
Gene Symbol: |
ERVK-32 |
ERVK-32
|
|
endogenous retrovirus group K member 32, envelope
|
|
158
|
0.522 |
0.692 |
|
0.010 |
None
|
1.000 |
1
|
0
|
1995 |
1995 |
STIN2-VNTR
|
|
serotonin transporter intronic VNTR enhancer
|
|
55
|
0.636 |
0.538 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2004 |
2004 |
Entrez Id: |
145624 |
Gene Symbol: |
PWAR1 |
PWAR1
|
|
Prader Willi/Angelman region RNA 1
|
|
246
|
0.490 |
0.769 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2019 |
2019 |
Entrez Id: |
192142 |
Gene Symbol: |
RLS1 |
RLS1
|
|
Restless legs syndrome, susceptibility to
|
|
37
|
0.705 |
0.423 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2017 |
2017 |
Entrez Id: |
23706 |
Gene Symbol: |
IBGC1 |
IBGC1
|
|
idiopathic basal ganglia calcification 1
|
|
7
|
0.861 |
0.154 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2015 |
2015 |
Entrez Id: |
2481 |
Gene Symbol: |
FRAXE |
FRAXE
|
|
fragile site, folic acid type, rare, fra(X)(q28) E
|
|
50
|
0.636 |
0.462 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2003 |
2003 |
Entrez Id: |
260402 |
Gene Symbol: |
IS1 |
IS1
|
|
Adolescent idiopathic scoliosis
|
|
83
|
0.593 |
0.615 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2019 |
2019 |
Entrez Id: |
26220 |
Gene Symbol: |
DGCR5 |
DGCR5
|
|
DiGeorge syndrome critical region gene 5
|
|
45
|
0.650 |
0.577 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2018 |
2018 |
Entrez Id: |
283120 |
Gene Symbol: |
H19 |
H19
|
|
H19 imprinted maternally expressed transcript
|
|
242
|
0.494 |
0.923 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2016 |
2016 |
HLA-DRB6
|
|
major histocompatibility complex, class II, DR beta 6 (pseudogene)
|
|
9
|
0.821 |
0.308 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2016 |
2016 |
Entrez Id: |
3342 |
Gene Symbol: |
HTC2 |
HTC2
|
|
hypertrichosis 2 (generalized, congenital)
|
|
511
|
0.392 |
0.808 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2007 |
2007 |
Entrez Id: |
378938 |
Gene Symbol: |
MALAT1 |
MALAT1
|
|
metastasis associated lung adenocarcinoma transcript 1
|
|
336
|
0.435 |
0.846 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2018 |
2018 |